Publications (original articles or review articles) published in 2022 from OUS - Rheumatology Research Group
32 publications found
Treatment Response to Tumor Necrosis Factor Inhibitors and Methotrexate Monotherapy in Adults With Juvenile Idiopathic Arthritis: Data From NOR-DMARD
J Rheumatol, 50 (4), 538-547
DOI 10.3899/jrheum.220645, PubMed 36379571
High-resolution computed tomography of the chest for the screening, re-screening and follow-up of systemic sclerosis-associated interstitial lung disease: a EUSTAR-SCTC survey
Clin Exp Rheumatol, 40 (10), 1951-1955
DOI 10.55563/clinexprheumatol/7ry6zz, PubMed 35819810
Patient preferences for the treatment of systemic sclerosis-associated interstitial lung disease: a discrete choice experiment
Rheumatology (Oxford), 61 (10), 4035-4046
DOI 10.1093/rheumatology/keac126, PubMed 35238334
Identification and functional characterization of a novel susceptibility locus for small vessel vasculitis with MPO-ANCA
Rheumatology (Oxford), 61 (8), 3461-3470
DOI 10.1093/rheumatology/keab912, PubMed 34888651
Target organ expression and biomarker characterization of chemokine CCL21 in systemic sclerosis associated pulmonary arterial hypertension
Front Immunol, 13, 991743
DOI 10.3389/fimmu.2022.991743, PubMed 36211384
Do tender joints in active psoriatic arthritis reflect inflammation assessed by ultrasound and magnetic resonance imaging?
Rheumatology (Oxford), 61 (2), 723-733
DOI 10.1093/rheumatology/keab384, PubMed 33895799
Anakinra in Patients With Systemic Juvenile Idiopathic Arthritis: Long-term Safety From the Pharmachild Registry
J Rheumatol, 49 (4), 398-407
DOI 10.3899/jrheum.210563, PubMed 35105709
Epidemiology of interstitial lung diseases and their progressive-fibrosing behaviour in six European countries
ERJ Open Res, 8 (1)
DOI 10.1183/23120541.00597-2021, PubMed 35083316
Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis From European Scleroderma Trials and Research
Chest, 163 (3), 586-598
DOI 10.1016/j.chest.2022.09.044, PubMed 36244404
Systemic sclerosis in the time of COVID-19
Lancet Rheumatol, 4 (8), e566-e575
DOI 10.1016/S2665-9913(22)00130-8, PubMed 35891634
Proteomic Profiling of Saliva and Tears in Radiated Head and Neck Cancer Patients as Compared to Primary Sjögren's Syndrome Patients
Int J Mol Sci, 23 (7)
DOI 10.3390/ijms23073714, PubMed 35409074
Representativeness of systemic sclerosis patients in interventional randomized trials: an analysis of the EUSTAR database
Rheumatology (Oxford), 61 (2), 743-755
DOI 10.1093/rheumatology/keab437, PubMed 33989387
Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort
RMD Open, 8 (2)
DOI 10.1136/rmdopen-2022-002477, PubMed 36328401
Identification of Novel Loci Shared by Juvenile Idiopathic Arthritis Subtypes Through Integrative Genetic Analysis
Arthritis Rheumatol, 74 (8), 1420-1429
DOI 10.1002/art.42129, PubMed 35347896
Complement C4 Copy Number Variation is Linked to SSA/Ro and SSB/La Autoantibodies in Systemic Inflammatory Autoimmune Diseases
Arthritis Rheumatol, 74 (8), 1440-1450
DOI 10.1002/art.42122, PubMed 35315244
A randomized, phase II study of sequential belimumab and rituximab in primary Sjögren's syndrome
JCI Insight, 7 (23)
DOI 10.1172/jci.insight.163030, PubMed 36477362
Nintedanib in Patients With Autoimmune Disease-Related Progressive Fibrosing Interstitial Lung Diseases: Subgroup Analysis of the INBUILD Trial
Arthritis Rheumatol, 74 (6), 1039-1047
DOI 10.1002/art.42075, PubMed 35199968
Multiomics analysis of rheumatoid arthritis yields sequence variants that have large effects on risk of the seropositive subset
Ann Rheum Dis, 81 (8), 1085-1095
DOI 10.1136/annrheumdis-2021-221754, PubMed 35470158
Computed tomography-based radiomics decodes prognostic and molecular differences in interstitial lung disease related to systemic sclerosis
Eur Respir J, 59 (5)
DOI 10.1183/13993003.04503-2020, PubMed 34649979
The attitudes and practices of physicians caring for patients with rheumatoid arthritis-associated interstitial lung disease: an international survey
Rheumatology (Oxford), 61 (4), 1459-1467
DOI 10.1093/rheumatology/keab552, PubMed 34260687
Serum markers of cardiac complications in a systemic sclerosis cohort
Sci Rep, 12 (1), 4661
DOI 10.1038/s41598-022-08815-8, PubMed 35304587
Personally Generated Quality of Life Outcomes in Adults With Juvenile Idiopathic Arthritis
J Rheumatol, 49 (10), 1138-1145
DOI 10.3899/jrheum.211245, PubMed 35569834
Validity and Reliability of Four Parent/Patient-Reported Outcome Measures for Juvenile Idiopathic Arthritis Remote Monitoring
Arthritis Care Res (Hoboken), 75 (2), 391-400
DOI 10.1002/acr.24855, PubMed 35015379
Dyspnoea and cough in patients with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial
Rheumatology (Oxford), 61 (11), 4397-4408
DOI 10.1093/rheumatology/keac091, PubMed 35150246
Automated segmentation of magnetic resonance bone marrow signal: a feasibility study
Pediatr Radiol, 52 (6), 1104-1114
DOI 10.1007/s00247-021-05270-x, PubMed 35107593
Whole body magnetic resonance imaging in healthy children and adolescents. Bone marrow appearances of the axial skeleton
Eur J Radiol, 154, 110425
DOI 10.1016/j.ejrad.2022.110425, PubMed 35843014
Serum B-cell activating factor and lung ultrasound B-lines in connective tissue disease related interstitial lung disease
Front Med (Lausanne), 9, 1066111
DOI 10.3389/fmed.2022.1066111, PubMed 36590969
Body composition in long-standing juvenile dermatomyositis: associations with disease activity, muscle strength and cardiometabolic measures
Rheumatology (Oxford), 61 (7), 2959-2968
DOI 10.1093/rheumatology/keab805, PubMed 34718443
Associations between cardiac and pulmonary involvement in patients with juvenile dermatomyositis-a cross-sectional study
Rheumatol Int, 42 (7), 1213-1220
DOI 10.1007/s00296-021-05071-3, PubMed 34984516
Whole body magnetic resonance imaging in healthy children and adolescents: Bone marrow appearances of the appendicular skeleton
Eur J Radiol, 153, 110365
DOI 10.1016/j.ejrad.2022.110365, PubMed 35617871
Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohort
Rheumatology (Oxford), 61 (12), 4786-4796
DOI 10.1093/rheumatology/keac188, PubMed 35348643
Plasma exchange and glucocorticoid dosing for patients with ANCA-associated vasculitis: a clinical practice guideline
BMJ, 376, e064597
DOI 10.1136/bmj-2021-064597, PubMed 35217581